Seeking to incentivize individuals to share their genetic code information, Nebula Genomics and Longenesis have joined in an exclusive collaboration. Nebula Genomics is a San Francisco-based company co-founded by genomics pioneer George Church, Ph.D., that is using blockchain to build a marketplace for genomic and clinical data, and Longenesis is a Hong Kong-based partnership between Insilico Medicine and the Bitfury Group that is applying deep learning and blockchain technologies to make a platform for the exchange of healthcare data.
“By allowing individuals and large data providers such as biobanks to maintain ownership of their genomic data on our platform and profit from it, Nebula Genomics seeks to incentivize generation of genomic data. In doing so, we will gather the data on a single network where it can be conveniently and securely accessed by researchers,” says Dr. Church. “In other words, we will make a marketplace that will create an equitable and efficient economy for genomic data. Lon genesis has built a similar platform that instead focuses on longitudinal health data, so our platforms complement one another very well.”
